Keep Me Logged In
CNBC's Eunice Yoon discusses the damage control coming out of GlaxoSmithKline, which says the charges out of China were disappointing and the company is commissioning its own review.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by